LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
Illinois IL
Legislatures
2025-2026 Regular Session
House
Bills
HB3168
IL
Illinois House Bill HB3168
Illinois 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
IL
Illinois 2025-2026 Regular Session
Illinois House Bill HB3168
Introduced
2/6/25
Refer
2/18/25
Refer
3/11/25
Refer
3/21/25
Caption
TIANEPTINE-RETAIL SALE PROHIB
Companion Bills
No companion bills found.
Previously Filed As
IL HB1720
TIANEPTINE PROHIBITION ACT
IL AB634
Tianeptine.
IL LD59
An Act to Ban the Drug Tianeptine
IL HB21
An Act To Amend Title 16 Of The Delaware Code Relating To Tianeptine.
IL S322
Establishes tianeptine as Schedule II controlled dangerous substance.
IL SB946
Further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.
IL LB475
Classify tianeptine as a controlled substance
IL HB06482
An Act Prohibiting Liquor Sales In Retailers That Sell Food Or Candy.
IL HB1504
Prohibiting retailers from engaging in price gouging on certain necessary products and services.
IL S632
Prohibits use by certain retailers of shipping box greater than two times volume of product being shipped.
Similar Bills
IL HB1720
TIANEPTINE PROHIBITION ACT
TX SB1868
Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.
CA AB634
Tianeptine.
LA SB154
Criminalizes the possession or distribution of kratom. (8/1/25)
PA HB377
Further providing for prohibited acts and penalties.
NJ S322
Establishes tianeptine as Schedule II controlled dangerous substance.
DE HB21
An Act To Amend Title 16 Of The Delaware Code Relating To Tianeptine.
PA SB946
Further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.